| FKBP1AP1 expression profile based on | ||||||||||||||||||||||||||||||
OV : Ovarian serous cystadenocarcinoma*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 3 samples.
| ||||||||||||||||||||||||||||||
OV : Ovarian serous cystadenocarcinoma*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 12 samples, while 2 samples from Amerian Indian and one sample from Native Hawaiians not considered in above plot.
| ||||||||||||||||||||||||||||||
OV : Ovarian serous cystadenocarcinoma*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient age information is not available for 1 sample.
| ||||||||||||||||||||||||||||||
OV : Ovarian serous cystadenocarcinoma*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Tumor grade information is not available for 3 samples, undetermined for 4 samples and borderline cancerous for 2 samples.
| ||||||||||||||||||||||||||||||
OV : Ovarian serous cystadenocarcinoma*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Whole exome sequencing data is not available for 87 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data.
| ||||||||||||||||||||||||||||||